The present invention relates to a surgical implant defined in the preamble of claim 1, in particular to an intervertebral implant, an intramedullary pin or an intrajoint prosthesis.
Intervertebral implants or other surgical implants comprising cavities designed to be traversed by bones in most instance will be filled during surgery with bones or bony materials in order to allow optimal bone growth through them (the so-called fusion of two vertebras in the case of two vertebras).
The state of the art includes the following procedures:
(a) filling with autologuous bone chips removed from the patient's iliac crest; this procedure frequently correlates with additional patient morbidity,
(b) filling the implants with autologuous bone removed from the adjacent vertebra as regards intervertebral implantations with anterior access,
(c) implant filling using a bony material; this material may be natural or entirely synthetic; if natural, there is a residual danger of infection both for an allogenic and a xenogenic material; moreover the physical properties of a bone-replacement material may fluctuate substantially when involving the various donor individuals and body removal sites.
The above state of the art is merely cited as background of the present invention and should not be construed having been actually published or being widely known at the time this application was filed.
The objective of the present invention is palliation. It aims to create an implant which when being implanted already contains an entirely synthetic bone replacement material even in the form of a composite product.
The above problem is solved by the present invention by an implant defined by the features of claim 1.
By resorting to an entirely synthetic bone replacement material, the invention allows averting all above cited drawbacks. As a result it also offers the advantage that—compared to natural bone replacement products—the danger of disease communication is precludes because of the absence of pathogenic proteins, germs, viruses or bacteria.
Preferably the entirely synthetic bone replacement material is made of a calcium phosphate, typically a beta tricalcium phosphate. This feature offers the advantage of using a ceramic of which the stoichiometric composition substantially corresponds to that of the human bone. Furthermore the time of degradation of beta tricalciumphosphate is neither too short nor too long, and consequently cavities or implant residues are averted in the course of degradation.
Also the present invention offers further advantages to the patient. In particular, on account of simplified surgery,
(a) the time of surgery is substantially shortened,
(b) the time under anesthesia is less, and
(c) the patient suffers less loss of blood, and, by selecting a synthetic bone replacement material, the properties of said material (porosity, pore size, mechanical compressive strength) are not subjected to fluctuations.
The bone replacement material may be in the form of a rigid element corresponding to the cavity geometry or alternatively in the form of a plastically deforming mass that can be introduced into said cavity.
In a particular embodiment mode, the implant cavity flares conically or cuneately toward the top or the bottom implant surface. As a result the entirely synthetic bone replacement material element inserted into said cavity is press-fitted into the cavity.
However the element also may be affixed by an appropriate fastener, preferably a screw or pin or a stop in the said cavity.
The implant of the invention may comprise a single cavity or several, typically in the latter case from two to eight mutually separate cavities.
Preferably the implant is designed as an intervertebral implant, though it also may be an intramedullary pin or in the form of another osteosynthetic implant or an intrajoint prosthesis.
In one embodiment of the present invention in the form of an intervertebral implant, same is preferably designed as a spacer unit comprising a top and a bottom surface which are appropriate to rest against the end plates of two adjacent vertebras. In this design the cavity does link the spacer unit's top surface to its bottom surface. Appropriately the top surface and/or the bottom surface of said spacer unit are structured in three dimensions, for instance being fluted, grooved, nubbed or in the form of other elevations or indentations.
Preferably the implant shall be transparent to x-rays, in particular consisting of a polymer such as PEEK. The advantage is that fusion may be assessed clinically.
In a further embodiment mode of the present invention, the bone replacement material is resorbing, preferably being hydroxyl apatite or tricalcium phosphate. This feature offers the advantage that because of material resorption, new bone tissue may grow back and need not force itself through the permanent material's pores.
The bone replacement material element advantageously exhibits a porosity of at least 25%, typically at least 35%, at least 50% of the pores exhibiting a diameter preferably in the range of 200 to 500μ.
In a further embodiment mode, the bone replacement material exhibits connections between the individual pores having diameters in the range of 10 to 500μ, preferably 200 to 400μ.
Illustratively the implant may be implemented in that a rigid element corresponding to the cavity geometry and made of an entirely synthetic bone replacement material is pressed into the implant cavity or affixed therein by appropriate fasteners. In another procedure, a moldable and preferably kneadable mass of an entirely synthetic bone replacement material preferably in granular form is introduced into the cavity where it shall be left in the uncured or cured state. This latter procedure also is appropriate for filling the cavities with bone replacement material during surgery.
The invention and its further embodiments are elucidated below in relation to the partly diagrammatic representation of an illustrative embodiment.
The implant shown in
As shown by
The spacer unit is made of PEEK whereas the elements 3 are made of porous hydroxyl apatite.
Number | Date | Country | Kind |
---|---|---|---|
202 05 016 U | Mar 2002 | DE | national |
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/CH03/00020 | 1/16/2003 | WO | 00 | 11/12/2004 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO03/082160 | 10/9/2003 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
4815454 | Dozier et al. | Mar 1989 | A |
5769897 | Harle | Jun 1998 | A |
5865845 | Thalgott | Feb 1999 | A |
5888222 | Coates et al. | Mar 1999 | A |
6039762 | McKay | Mar 2000 | A |
6398811 | McKay | Jun 2002 | B1 |
6485517 | Michelson | Nov 2002 | B1 |
20010047208 | Michelson | Nov 2001 | A1 |
20030023306 | Liu et al. | Jan 2003 | A1 |
20030023312 | Thalgott | Jan 2003 | A1 |
20050192669 | Zdeblick et al. | Sep 2005 | A1 |
Number | Date | Country |
---|---|---|
9856319 | Dec 1998 | WO |
Number | Date | Country | |
---|---|---|---|
20050065604 A1 | Mar 2005 | US |